Neuroendoscopic Minimally Invasive Intracranial Hematoma Removal and Traditional Craniotomy in the Treatment of Hypertensive Intracerebral Hemorrhage
Stroke remains one of the major health problems in both industrialized and developing countries. Spontaneous hypertensive intracerebral hemorrhage (SHICH) accounts for 30-60% of all stroke admissions and is considered a poor prognostic factor. This article aims to demonstrate whether minimally invasive neuroendoscopic evacuation of intracranial hematoma is the most effective treatment for spontaneous hypertensive intracerebral hemorrhage.A comparison was made between neuroendoscopic minimally invasive intracranial hematoma removal and traditional craniotomy. The transparent sheath of neuroendoscopy is made of silicone rubber and derived from the chest 21F as the working channel of the catheter. Forty-three patients were recruited, of whom 25 underwent neuroendoscopic minimally invasive intracranial hematoma removal and 18 underwent traditional craniotomy. The mortality of craniotomy group was significantly higher than that of neuroendoscopy group. The data were n=12 (63.2%) and N =7 (36.8%) (p < 0.005). The patients with Glasgow Prognostic Scale were higher in neuroendoscopy group (n = 18 (75%) and craniotomy group (n = 6 (25%). Kaplan Meier method was used to analyze the survival rate. It was found that the survival rate of patients undergoing neuroendoscopic minimally invasive removal of intracranial hematoma was significantly higher than that of traditional craniotomy group after 6 months of follow-up. In the treatment of hypertensive intracerebral hemorrhage, neuroendoscopic minimally invasive intracranial hematoma clearance procedure is faster, safer and has a higher survival rate than traditional craniotomy.